Evidence map›Paper›PMID 42483429›Full record

ArticleFrontiers in digital health2026

Longitudinal voice biomarker trajectory modelling for Parkinson's disease severity: domain-adaptive transfer learning on mPower real-world smartphone data.

Deepika Roselind Johnson, G Logeswari

Abstract read
In one paragraph

Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Deepika Roselind JohnsonSchool of Computer Science and Engineering, Vellore Institute of Technology, Chennai Campus, Chennai, India.
G LogeswariSchool of Computer Science and Engineering, Vellore Institute of Technology, Chennai Campus, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Speech and voice changes affect up to 90% of people with Parkinson's disease (PD), a progressive neurodegenerative disorder affecting approximately 10 million people worldwide. Although continuous monitoring of disease severity is clinically important, most existing voice-based computational approaches focus on binary PD-versus-control classification and do not model longitudinal symptom progression. To address this gap, we propose a domain-adaptive transformer model, DAT-PD, for predicting continuous PD severity trajectories from real-world smartphone voice recordings. Methods: DAT-PD was developed using the public mPower dataset, comprising 58,247 voice recordings from 5,800 participants. The proposed pipeline included noise-aware acoustic preprocessing, extraction of extended Geneva Minimalistic Acoustic Parameter Set (eGeMAPS) features, a domain-adaptive attention mechanism to reduce cross-device and cross-environment variability and a longitudinal trajectory decoder. The model was trained, inferred, and evaluated using continuous MDS-UPDRS Part-II scores as the sole prediction target. Confounder-aware domain adaptation was incorporated to address demographic imbalance, including the age gap between the PD cohort and healthy controls. Robustness was further evaluated under harsh acoustic conditions with signal-to-noise ratios as low as 0 dB. Results: On the held-out test set, DAT-PD achieved a mean absolute error (MAE) of 2.74 MDS-UPDRS units (95% CI: 2.44-3.01), root mean squared error (RMSE) of 3.61 (95% CI: 3.18-4.04), and R² of 0.93 (95% CI: 0.91-0.95), outperforming six state-of-the-art baseline models. eGeMAPS features substantially outperformed MFCC-only representations, reducing MAE from 5.21 to 2.74. SHAP-based explainability identified MFCC-2, Shimmer (APQ5) and Jitter as the most influential longitudinal voice biomarkers. Discussion: The superior performance of DAT-PD suggests that domain-adaptive longitudinal modeling can effectively capture clinically meaningful voice-based severity trajectories in PD. The advantage of eGeMAPS over MFCC-only features is likely due to its ability to represent phonatory and prosodic characteristics relevant to PD dysarthria, including F0 dynamics, loudness contour, shimmer, jitter and spectral flux. By maintaining robustness under noisy real-world acoustic conditions, DAT-PD supports unsupervised home-based monitoring using standard smartphones. These findings align with the Bridge2AI-Voice research agenda and position DAT-PD as a clinically implementable, non-invasive tool for continuous PD severity assessment.

Indexed as

domain adaptationlongitudinal modellingMDS-UPDRS predictionMPOWERParkinson's diseaseseverity trackingtransfer learningvoice biomarkers

Identifiers

PMID42483429
PMCPMC13385221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.